Executive Chairman
Mr. Sørensen was appointed Chairman of Ferring’s Board of Directors in July 2021 and became Executive Chairman in April 2022. He has more than 30 years’ management experience in the pharmaceutical industry and was President and CEO of Novo Nordisk A/S from 2000 until 2016. He is Chair of the Board of the Novo Nordisk Foundation and Novo Holdings A/S, a Board member of Thermo Fisher Scientific Inc. (U.S.), Essity AB (Sweden) and Jungbunzlauer Suisse A.G. (Switzerland), and Chair of the Advisory Board of Axcel Management A/S (Denmark). Mr. Sørensen serves as a Post-doctoral Lecturer in the Faculty of Science at the University of Copenhagen, and in the Center for Corporate Governance at Copenhagen Business School in Denmark.